[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Erasca Inc (ERAS)

Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,369,339
  • Shares Outstanding, K 310,985
  • Annual Sales, $ 0 K
  • Annual Income, $ -124,550 K
  • EBIT $ -293 M
  • EBITDA $ -295 M
  • 60-Month Beta 0.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.07

Options Overview Details

View History
  • Implied Volatility 84.96% (-2.51%)
  • Historical Volatility 69.84%
  • IV Percentile 2%
  • IV Rank 1.80%
  • IV High 404.74% on 09/16/25
  • IV Low 79.11% on 05/19/26
  • Expected Move (DTE 3) 0.22 (1.57%)
  • Put/Call Vol Ratio 0.51
  • Today's Volume 473
  • Volume Avg (30-Day) 1,341
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 96,933
  • Open Int (30-Day) 104,095
  • Expected Range 13.83 to 14.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 6
  • High Estimate $-0.11
  • Low Estimate $-0.13
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.80 +43.37%
on 05/14/26
15.03 -6.52%
on 06/01/26
+3.67 (+35.36%)
since 05/12/26
3-Month
8.70 +61.49%
on 04/28/26
24.28 -42.13%
on 04/23/26
-0.60 (-4.10%)
since 03/12/26
52-Week
1.21 +1,061.16%
on 06/27/25
24.28 -42.13%
on 04/23/26
+12.52 (+818.30%)
since 06/12/25

Most Recent Stories

More News
ERAS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April...

ERAS : 14.05 (+0.29%)
Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”)...

ERAS : 14.05 (+0.29%)
Erasca, Inc. (ERAS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS ) investors concerning the Company’s possible violations...

ERAS : 14.05 (+0.29%)
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS ...

ERAS : 14.05 (+0.29%)
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit

NEW YORK , June 11, 2026 /PRNewswire/ --

ERAS : 14.05 (+0.29%)
INVESTOR ALERT: Securities Class Action Filed Against Erasca, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ:ERAS)...

ERAS : 14.05 (+0.29%)
Rosen Law Firm Urges Erasca, Inc. (NASDAQ: ERAS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive...

ERAS : 14.05 (+0.29%)
ERAS INVESTOR ALERT: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead the Erasca Class Action Lawsuit

SAN DIEGO , June 11, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025...

ERAS : 14.05 (+0.29%)
ERAS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Erasca (ERA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their Options...

ERAS : 14.05 (+0.29%)
Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS ) on behalf of investors concerning the Company’s...

ERAS : 14.05 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 15.15
2nd Resistance Point 14.88
1st Resistance Point 14.46
Last Price 14.05
1st Support Level 13.77
2nd Support Level 13.50
3rd Support Level 13.08

See More

52-Week High 24.28
Fibonacci 61.8% 15.47
Last Price 14.05
Fibonacci 50% 12.75
Fibonacci 38.2% 10.02
52-Week Low 1.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.